CivicaScript® to distribute low-cost biosimilar to treat chronic inflammatory conditions

January launch of ustekinumab-aauz to CivicaScript customers will expand company's rapidly growing product portfolio LEHI, Utah, Aug. 5, 2025 /PRNewswire/ -- CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced that it...